Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect
- 30 April 2012
- journal article
- Published by Elsevier BV in Bone
- Vol. 50 (4), 1012-1018
- https://doi.org/10.1016/j.bone.2012.01.027
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Regulation of Human Adipose-Derived Stromal Cell Osteogenic Differentiation by Insulin-Like Growth Factor-1 and Platelet-Derived Growth Factor-αPlastic and Reconstructive Surgery, 2010
- Mesenchymal Stem Cells Expressing Osteogenic and Angiogenic Factors Synergistically Enhance Bone Formation in a Mouse Model of Segmental Bone DefectMolecular Therapy, 2010
- Hyperoxia, Endothelial Progenitor Cell Mobilization, and Diabetic Wound HealingAntioxidants and Redox Signaling, 2008
- Homing and engraftment of progenitor cells: A prerequisite for cell therapyJournal of Molecular and Cellular Cardiology, 2008
- Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2008
- The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammationBlood, 2008
- Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1αJCI Insight, 2007
- Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100Blood, 2006
- Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defectJCI Insight, 2006
- G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanismBlood, 2006